Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A00212 | 35183303 | Lancet Diabetes Endocrinol | A global view of the interplay between non-alcoholic fatty liver disease and diabetes. | 2022 | Details |
| A00213 | 35182670 | J Ethnopharmacol | Gryllus bimaculatus De Geer hydrolysates alleviate lipid accumulation, inflammation, and endoplasmic reticulum stress in palmitic acid-treated human hepatoma G2 cells. | 2022 | Details |
| A00214 | 35182330 | Mol Cell Biochem | Menin regulates lipid deposition in mouse hepatocytes via interacting with transcription factor FoxO1. | 2022 | Details |
| A00215 | 35182007 | Liver Int | The NAFLD-MAFLD debate: Is there a Consensus-on-Consensus methodology? | 2022 | Details |
| A00216 | 35181565 | Clin Gastroenterol Hepatol | UNOS Down-staging Criteria for Liver Transplantation of Hepatocellular Carcinoma: Systematic Review and Meta-Analysis of 25 Studies. | 2022 | Details |
| A00217 | 35181350 | Diabetes Res Clin Pract | Metabolic Changes Induced by Dapagliflozin, an SGLT2 Inhibitor, in Japanese Patients with Type 2 Diabetes Treated by Oral Anti-diabetic Agents: A Randomized, Clinical Trial. | 2022 | Details |
| A00218 | 35180651 | Pathol Res Pract | Stage-dependent expression of fibrogenic markers in alcohol-related liver disease. | 2022 | Details |
| A00219 | 35178989 | Zhongguo Zhong Yao Za Zhi | [Mechanism of Zexie Decoction in improvement of nonalcoholic fatty liver disease based on LKB1/AMPK/PGC-1α pathway]. | 2022 | Details |
| A00220 | 35178663 | Hepatol Int | Distinctive clinical and genetic features of lean vs overweight fatty liver disease using the UK Biobank. | 2022 | Details |
| A00221 | 35178496 | APL Bioeng | Development of resveratrol with thiolated alginate as a supplement to prevent nonalcoholic fatty liver disease (NAFLD). | 2022 | Details |
| A00222 | 35178204 | Caspian J Intern Med | Effect of Oral and parenteral routes of vitamin D supplementation on serum 25(OH) vitamin D levels in patients with non-alcoholic fatty liver disease. | 2022 | Details |
| A00223 | 35178098 | Evid Based Complement Alternat Med | A Network Pharmacology Study on the Active Components and Targets of the Radix Ginseng and Radix Bupleuri Herb Pair for Treating Nonalcoholic Fatty Liver Disease. | 2022 | Details |
| A00224 | 35178085 | Gastroenterol Res Pract | The Risk Factors of Nonalcoholic Fatty Liver Disease in Morbidly Obese Patients Undergoing Bariatric Surgery in Iran. | 2022 | Details |
| A00225 | 35176709 | Biomed Pharmacother | Purendan alleviates non-alcoholic fatty liver disease in aged type 2 diabetic rats via regulating mTOR/S6K1/SREBP-1c signaling pathway. | 2022 | Details |
| A00226 | 35176096 | PLoS One | Lifestyle changes in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis. | 2022 | Details |
| A00227 | 35176047 | PLoS One | Neck circumference as a screening measure for identifying NAFLD among a group of academic employees in Bangkok, Thailand. | 2022 | Details |
| A00228 | 35174539 | J Gastroenterol Hepatol | Validation of five hepatic steatosis algorithms in metabolic- associated fatty liver disease: a population based study. | 2022 | Details |
| A00229 | 35174500 | J Sci Food Agric | Identification of a novel probiotic and its protective effects on NAFLD via modulating gut microbial community. | 2022 | Details |
| A00230 | 35174209 | Front Mol Biosci | ER Disposal Pathways in Chronic Liver Disease: Protective, Pathogenic, and Potential Therapeutic Targets. | 2022 | Details |
| A00231 | 35174195 | Front Nutr | Dietary Vitamin C Intake Is Associated With Improved Liver Function and Glucose Metabolism in Chinese Adults. | 2022 | Details |
| A00232 | 35173677 | Front Endocrinol (Lausanne) | Validation of Controlled Attenuation Parameter Measured by FibroScan as a Novel Surrogate Marker for the Evaluation of Metabolic Derangement. | 2022 | Details |
| A00233 | 35173541 | Int J Biol Sci | The role of MLKL in Hepatic Ischemia-Reperfusion Injury of Alcoholic Steatotic Livers. | 2022 | Details |
| A00234 | 35173224 | Sci Rep | A robust gene expression signature for NASH in liver expression data. | 2022 | Details |
| A00235 | 35172845 | Nutr Metab (Lond) | Effects of exercise on high-fat diet-induced non-alcoholic fatty liver disease and lipid metabolism in ApoE knockout mice. | 2022 | Details |
| A00236 | 35172328 | J Clin Endocrinol Metab | Growth hormone and insulin-like growth factor I regulation of nonalcoholic fatty liver disease. | 2022 | Details |
| A00237 | 35171499 | Ther Innov Regul Sci | Attitudes of Chinese Patients with Non-alcoholic Fatty Liver Disease Toward Participation in Clinical Trials from a National Multicenter Survey. | 2022 | Details |
| A00238 | 35171411 | Med Biol Eng Comput | Exploring diet associations with Covid-19 and other diseases: a Network Analysis-based approach. | 2022 | Details |
| A00239 | 35171314 | Pathologe | [Histopathological evaluation of nonalcoholic fatty liver disease : Automated evaluation of liver biopsies]. | 2022 | Details |
| A00240 | 35171164 | Food Funct | Tangeretin improves hepatic steatosis and oxidative stress through the Nrf2 pathway in high fat diet-induced nonalcoholic fatty liver disease mice. | 2022 | Details |
| A00241 | 35170435 | Saudi J Gastroenterol | Correlation between serum total bile acid and nonalcoholic fatty liver disease: A cross-sectional study. | 2022 | Details |
| A00242 | 35170434 | Saudi J Gastroenterol | Saudi association for the study of liver diseases and transplantation position statement on the hepatology workforce in Saudi Arabia. | -- | Details |
| A00243 | 35170400 | Bioengineered | Hepatoprotective mechanism of Silybum marianum on nonalcoholic fatty liver disease based on network pharmacology and experimental verification. | 2022 | Details |
| A00244 | 35169195 | Sci Rep | Relationship between the dynamics of non-alcoholic fatty liver disease and incident diabetes mellitus. | 2022 | Details |
| A00245 | 35168828 | Nutr Metab Cardiovasc Dis | Visceral adipose tissue quality was associated with nonalcoholic fatty liver disease, independent of its quantity. | 2022 | Details |
| A00246 | 35167495 | JCI Insight | Ethnic and gender differences in hepatic lipid content and related cardiometabolic parameters in lean individuals. | 2022 | Details |
| A00247 | 35167194 | J Diabetes Investig | Fatty liver with metabolic disorder, such as metabolic dysfunction-associated fatty liver disease, indicates high risk for developing diabetes mellitus. | 2022 | Details |
| A00248 | 35166723 | Clin Transl Gastroenterol | Relationship between hepatic gene expression, intestinal microbiota and inferred functional metagenomic analysis in NAFLD. | 2022 | Details |
| A00249 | 35166009 | Diabetes Obes Metab | Effects of empagliflozin on markers of liver steatosis and fibrosis and their relationship to cardiorenal outcomes. | 2022 | Details |
| A00250 | 35165568 | Cureus | Efficacy of Lipid Ratios and Platelet Distribution Width for Assessment of Liver Fibrosis in Patients With Non-alcoholic Fatty Liver Disease. | 2022 | Details |
| A00251 | 35164657 | Bioengineered | Liraglutide inhibits receptor for advanced glycation end products (RAGE)/reduced form of nicotinamide-adenine dinucleotide phosphate (NAPDH) signaling to ameliorate non-alcoholic fatty liver disease (NAFLD) in vivo and vitro. | 2022 | Details |
| A00252 | 35164326 | Molecules | Hyaluronated and PEGylated Liposomes as a Potential Drug-Delivery Strategy to Specifically Target Liver Cancer and Inflammatory Cells. | 2022 | Details |
| A00253 | 35164140 | Molecules | A Comparison of the Gene Expression Profiles of Non-Alcoholic Fatty Liver Disease between Animal Models of a High-Fat Diet and Methionine-Choline-Deficient Diet. | 2022 | Details |
| A00254 | 35164079 | Molecules | Genistein-Opportunities Related to an Interesting Molecule of Natural Origin. | 2022 | Details |
| A00255 | 35163991 | Molecules | Sitagliptin Is More Effective Than Gliclazide in Preventing Pro-Fibrotic and Pro-Inflammatory Changes in a Rodent Model of Diet-Induced Non-Alcoholic Fatty Liver Disease. | 2022 | Details |
| A00256 | 35163881 | Molecules | The Anti-Adiposity Mechanisms of Ampelopsin and Vine Tea Extract in High Fat Diet and Alcohol-Induced Fatty Liver Mouse Models. | 2022 | Details |
| A00257 | 35163821 | Int J Mol Sci | Proglumide Reverses Nonalcoholic Steatohepatitis by Interaction with the Farnesoid X Receptor and Altering the Microbiome. | 2022 | Details |
| A00258 | 35163521 | Int J Mol Sci | The Regulatory Role of the Central and Peripheral Serotonin Network on Feeding Signals in Metabolic Diseases. | 2022 | Details |
| A00259 | 35163026 | Int J Mol Sci | Development of Thyroid Hormones and Synthetic Thyromimetics in Non-Alcoholic Fatty Liver Disease. | 2022 | Details |
| A00260 | 35162992 | Int J Mol Sci | Emerging Insights on the Diverse Roles of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) in Chronic Liver Diseases: Cholesterol Metabolism and Beyond. | 2022 | Details |
| A00261 | 35162967 | Int J Mol Sci | Quercetin Reduces Lipid Accumulation in a Cell Model of NAFLD by Inhibiting De Novo Fatty Acid Synthesis through the Acetyl-CoA Carboxylase 1/AMPK/PP2A Axis. | 2022 | Details |
| A00262 | 35162956 | Int J Mol Sci | Emergent Roles of Circular RNAs in Metabolism and Metabolic Disorders. | 2022 | Details |
| A00263 | 35162699 | Int J Environ Res Public Health | Association of Muscle Strength with Non-Alcoholic Fatty Liver Disease in Korean Adults. | 2022 | Details |
| A00264 | 35162067 | Int J Environ Res Public Health | The Association between Serum Uric Acid Levels and 10-Year Cardiovascular Disease Risk in Non-Alcoholic Fatty Liver Disease Patients. | 2022 | Details |
| A00265 | 35160340 | J Clin Med | Effects of Moderate Alcohol Consumption in Non-Alcoholic Fatty Liver Disease. | 2022 | Details |
| A00266 | 35160329 | J Clin Med | Influence of Body Mass Index, Cancer Type and Treatment on Long-Term Metabolic and Liver Outcomes in Childhood Cancer Survivors. | 2022 | Details |
| A00267 | 35160204 | J Clin Med | Liraglutide + PYY3-36 Combination Therapy Mimics Effects of Roux-en-Y Bypass on Early NAFLD Whilst Lacking-Behind in Metabolic Improvements. | 2022 | Details |
| A00268 | 35160087 | J Clin Med | Crosstalk between Irisin Levels, Liver Fibrogenesis and Liver Damage in Non-Obese, Non-Diabetic Individuals with Non-Alcoholic Fatty Liver Disease. | 2022 | Details |
| A00269 | 35159371 | Cells | The Origins of NAFLD: The Potential Implication of Intrauterine Life and Early Postnatal Period. | 2022 | Details |
| A00270 | 35159342 | Cells | The Translational Bridge between Inflammation and Hepatocarcinogenesis. | 2022 | Details |
| A00271 | 35159219 | Cells | S-Adenosylmethionine: From the Discovery of Its Inhibition of Tumorigenesis to Its Use as a Therapeutic Agent. | 2022 | Details |
| A00272 | 35158328 | J Physiol Pharmacol | Current approach to hepatobiliary manifestations in inflammatory bowel disease. | 2022 | Details |
| A00273 | 35158055 | Clin Gastroenterol Hepatol | Statin Use and Reduced Hepatocellular Carcinoma Risk in Patients With Nonalcoholic Fatty Liver Disease. | 2022 | Details |
| A00274 | 35157960 | J Hepatol | Hepatic lymphatic vascular system in health and disease. | 2022 | Details |
| A00275 | 35154670 | Food Sci Nutr | The effect of Spirulina sauce, as a functional food, on cardiometabolic risk factors, oxidative stress biomarkers, glycemic profile, and liver enzymes in nonalcoholic fatty liver disease patients: A randomized double-blinded clinical trial. | 2021 | Details |
| A00276 | 35154609 | Gastroenterol Hepatol Bed Bench | Predictors of metabolic-associated fatty liver disease (MAFLD) in adults: a population-based study in Northeastern Iran. | 2021 | Details |
| A00277 | 35154608 | Gastroenterol Hepatol Bed Bench | Assessment of common and differentially expressed proteins between diabetes mellitus and fatty liver disease: a network analysis. | 2021 | Details |
| A00278 | 35154523 | Arch Med Sci | Fibroblast growth factor 21 levels and liver inflammatory biomarkers in obese subjects after weight loss. | 2021 | Details |
| A00279 | 35154005 | Front Endocrinol (Lausanne) | Novel Subgroups and Chronic Complications of Diabetes in Middle-Aged and Elderly Chinese:A Prospective Cohort Study. | 2022 | Details |
| A00280 | 35153490 | Int J Tryptophan Res | Intestinal Dysbiosis, the Tryptophan Pathway and Nonalcoholic Steatohepatitis. | 2022 | Details |
| A00281 | 35153138 | Hepatobiliary Pancreat Dis Int | Prevalence and characteristics of MAFLD in Chinese adults aged 40 years or older: A community-based study. | 2022 | Details |
| A00282 | 35152974 | Adv Clin Chem | Advances in fibrosis biomarkers in nonalcoholic fatty liver disease. | 2021 | Details |
| A00283 | 35152674 | Zhonghua Gan Zang Bing Za Zhi | [Study on the diagnostic value of transient elastography, APRI and FIB-4 for liver fibrosis in children with non-alcoholic fatty liver disease]. | 2022 | Details |
| A00284 | 35152673 | Zhonghua Gan Zang Bing Za Zhi | [Mechanism study of the protective effects of selective cyclooxygenase-2 enzyme inhibitors on the liver of rats with type 2 diabetes mellitus combined with nonalcoholic steatohepatitis via Rho/ROCK pathway]. | 2022 | Details |
| A00285 | 35152669 | Zhonghua Gan Zang Bing Za Zhi | [Study on the relationship between nonalcoholic fatty liver disease and hepatocellular carcinoma in patients with prior hepatitis B virus infection]. | 2022 | Details |
| A00286 | 35152526 | Liver Int | Risk of hepatic and extrahepatic cancer in NAFLD: A population-based cohort study. | 2022 | Details |
| A00287 | 35152446 | Hepatology | FGF4 protects the liver from nonalcoholic fatty liver disease by activating the AMP-activated protein kinase-Caspase 6 signal axis. | 2022 | Details |
| A00288 | 35152443 | J Food Sci | Bentong ginger oleoresin mitigates liver injury and modulates gut microbiota in mouse with nonalcoholic fatty liver disease induced by high-fat diet. | 2022 | Details |
| A00290 | 35151246 | Folia Biol (Praha) | Luteoloside Ameliorates Palmitic Acid-Induced in Vitro Model of Non-alcoholic Fatty Liver Disease via Activating STAT3-Triggered Hepatocyte Regeneration. | 2021 | Details |
| A00291 | 35150905 | Mol Metab | ITCH E3 ubiquitin ligase downregulation compromises hepatic degradation of branched-chain amino acids. | 2022 | Details |
| A00292 | 35150314 | Abdom Radiol (NY) | Clinical evaluation of grayscale and linear scale hepatorenal indices for fatty liver quantification: a prospective study of a native Chinese population. | 2022 | Details |
| A00293 | 35148806 | Nutr Metab (Lond) | Copper-catalyzed dicarbonyl stress in NAFLD mice: protective effects of Oleuropein treatment on liver damage. | 2022 | Details |
| A00294 | 35148334 | PLoS One | Procollagen C-Proteinase Enhancer-1 (PCPE-1) deficiency in mice reduces liver fibrosis but not NASH progression. | 2022 | Details |
| A00295 | 35147926 | J Endocrinol Invest | Risk of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis: an updated systematic review and meta-analysis of observational studies. | 2022 | Details |
| A00296 | 35147302 | Hepatol Commun | Effect of Omega-3 Polyunsaturated Fatty Acids on Lipid Metabolism in Patients With Metabolic Syndrome and NAFLD. | 2022 | Details |
| A00297 | 35147274 | Eur J Neurol | Non-alcoholic fatty liver disease and stroke: A Mendelian randomization study. | 2022 | Details |
| A00298 | 35146945 | Hepatol Commun | A Genetic and Metabolic Staging System for Predicting the Outcome of Nonalcoholic Fatty Liver Disease. | 2022 | Details |
| A00300 | 35145074 | Nat Commun | Small molecule SWELL1 complex induction improves glycemic control and nonalcoholic fatty liver disease in murine Type 2 diabetes. | 2022 | Details |
| A00301 | 35144542 | BMC Gastroenterol | Contribution of classification based on ferroptosis-related genes to the heterogeneity of MAFLD. | 2022 | Details |
| A00302 | 35144365 | Minerva Gastroenterol (Torino) | Non-invasive biomarkers of non-alcoholic fatty liver disease in patients with Metabolic Syndrome: insights from the RESOLVE study. | 2022 | Details |
| A00303 | 35144334 | Endocrinol Metab (Seoul) | Dulaglutide Ameliorates Palmitic Acid-Induced Hepatic Steatosis by Activating FAM3A Signaling Pathway. | 2022 | Details |
| A00304 | 35144052 | Redox Biol | The role of selenium in type-2 diabetes mellitus and its metabolic comorbidities. | 2022 | Details |
| A00305 | 35143711 | Clin Transl Sci | Hepatoprotective effects of semaglutide, lanifibranor and dietary intervention in the GAN diet-induced obese and biopsy-confirmed mouse model of NASH. | 2022 | Details |
| A00306 | 35143562 | PLoS One | Rural-Urban differentials in prevalence, spectrum and determinants of Non-alcoholic Fatty Liver Disease in North Indian population. | 2022 | Details |
| A00307 | 35143431 | Curr Opin Gastroenterol | Metabolic dysfunction-associated fatty liver disease: a year in review. | 2022 | Details |
| A00308 | 35143415 | Aging (Albany NY) | Hesperidin suppresses ERS-induced inflammation in the pathogenesis of non-alcoholic fatty liver disease. | 2022 | Details |
| A00310 | 35142988 | Curr Gastroenterol Rep | Models to Predict Development or Recurence of Hepatocellular Carcinoma (HCC) in Patients with Advanced Hepatic Fibrosis. | 2022 | Details |
| A00311 | 35142615 | Diagn Interv Radiol | Proton density fat fraction: magnetic resonance imaging applications beyond the liver. | 2022 | Details |
| A00314 | 35141790 | Mamm Genome | RMRP inhibition prevents NAFLD progression in rats via regulating miR-206/PTPN1 axis. | 2022 | Details |
| A00315 | 35141703 | Front Oral Health | Diet-Induced Non-alcoholic Fatty Liver Disease and Associated Gut Dysbiosis Are Exacerbated by Oral Infection. | 2022 | Details |
| A00316 | 35140621 | Front Pharmacol | Limonin, an AMPK Activator, Inhibits Hepatic Lipid Accumulation in High Fat Diet Fed Mice. | 2022 | Details |